Fig. 6.
Fig. 6. MMP-2 and MMP-9 secretion by bone marrow plasma cells. The patient with nonactive MM was in the plateau phase; the patient with active MM was at relapse; the control was a patient affected with anemia due to iron deficiency. (A) SDS-PAGE gelatin zymography of plasma cell CM samples. Note the white bands against a dark background with an apparent molecular weight of 62 kD and 88 kD, corresponding to the gelatinolytic regions of activated (cleaved) MMP-2 and MMP-9, respectively. Measurement of the intensity of the bands, as evaluated by computerized image analysis, is shown in (B). The assay was performed in duplicate for each CM. Reproducibility was ≤±20% of the mean intensity value. The lowest (third) band in the lane of the active MM patient represents the 54-kD cleaved form of MMP-2,2 which is sometimes present in the CM of both nonactive and active MM patients, but is not correlated with disease activity.

MMP-2 and MMP-9 secretion by bone marrow plasma cells. The patient with nonactive MM was in the plateau phase; the patient with active MM was at relapse; the control was a patient affected with anemia due to iron deficiency. (A) SDS-PAGE gelatin zymography of plasma cell CM samples. Note the white bands against a dark background with an apparent molecular weight of 62 kD and 88 kD, corresponding to the gelatinolytic regions of activated (cleaved) MMP-2 and MMP-9, respectively. Measurement of the intensity of the bands, as evaluated by computerized image analysis, is shown in (B). The assay was performed in duplicate for each CM. Reproducibility was ≤±20% of the mean intensity value. The lowest (third) band in the lane of the active MM patient represents the 54-kD cleaved form of MMP-2,2 which is sometimes present in the CM of both nonactive and active MM patients, but is not correlated with disease activity.

Close Modal

or Create an Account

Close Modal
Close Modal